BCAB
Price
$0.45
Change
-$0.01 (-2.17%)
Updated
Sep 2 closing price
Capitalization
26.3M
63 days until earnings call
KYMR
Price
$40.69
Change
-$0.51 (-1.24%)
Updated
Sep 2 closing price
Capitalization
2.91B
57 days until earnings call
Interact to see
Advertisement

BCAB vs KYMR

Header iconBCAB vs KYMR Comparison
Open Charts BCAB vs KYMRBanner chart's image
BioAtla
Price$0.45
Change-$0.01 (-2.17%)
Volume$548.15K
Capitalization26.3M
Kymera Therapeutics
Price$40.69
Change-$0.51 (-1.24%)
Volume$1.25M
Capitalization2.91B
BCAB vs KYMR Comparison Chart in %
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. KYMR commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Buy and KYMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (BCAB: $0.45 vs. KYMR: $40.69)
Brand notoriety: BCAB and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 81% vs. KYMR: 193%
Market capitalization -- BCAB: $26.3M vs. KYMR: $2.91B
BCAB [@Biotechnology] is valued at $26.3M. KYMR’s [@Biotechnology] market capitalization is $2.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCAB and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 6 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • BCAB’s TA Score: 6 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than KYMR.

Price Growth

BCAB (@Biotechnology) experienced а +10.16% price change this week, while KYMR (@Biotechnology) price change was -7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.48%. For the same industry, the average monthly price growth was +24.35%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

BCAB is expected to report earnings on Nov 05, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.91B) has a higher market cap than BCAB($26.3M). KYMR YTD gains are higher at: 2.411 vs. BCAB (-22.953). BCAB has higher annual earnings (EBITDA): -63.02M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. BCAB (18.2M). BCAB has less debt than KYMR: BCAB (6.05M) vs KYMR (85.7M). KYMR has higher revenues than BCAB: KYMR (44.7M) vs BCAB (11M).
BCABKYMRBCAB / KYMR
Capitalization26.3M2.91B1%
EBITDA-63.02M-267.03M24%
Gain YTD-22.9532.411-952%
P/E RatioN/AN/A-
Revenue11M44.7M25%
Total Cash18.2M665M3%
Total Debt6.05M85.7M7%
TECHNICAL ANALYSIS
Technical Analysis
BCABKYMR
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
76%
Momentum
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
73%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHINX13.510.01
+0.07%
Centre Global Infrastructure Investor
IRMTX10.28-0.03
-0.29%
Voya Russell Mid Cap Index Port S2
GSXCX28.23-0.09
-0.32%
abrdn US Small Cap Equity C
CSMUX25.67-0.12
-0.47%
Carillon Scout Mid Cap R-6
HCAIX112.94-1.47
-1.28%
Harbor Capital Appreciation Inv

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with KYMR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+8.45%
KYMR - BCAB
38%
Loosely correlated
-1.32%
CTMX - BCAB
37%
Loosely correlated
-0.49%
DNLI - BCAB
36%
Loosely correlated
-2.43%
NVO - BCAB
35%
Loosely correlated
+0.62%
GALT - BCAB
34%
Loosely correlated
+0.71%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.32%
NRIX - KYMR
67%
Closely correlated
-0.74%
VERA - KYMR
58%
Loosely correlated
-2.92%
CGON - KYMR
56%
Loosely correlated
+0.39%
LYRA - KYMR
53%
Loosely correlated
-0.71%
IDYA - KYMR
53%
Loosely correlated
-1.52%
More